5/23/2022  5:36:39 PM Chg. 0.000 Volume Bid5/23/2022 Ask5:36:39 PM Market Capitalization Dividend Y. P/E Ratio
41.600EUR 0.00% 4,357
Turnover: 184,256.750
-Bid Size: - -Ask Size: - 797.3 mill.EUR 0.31% 5.96

Business description

Dräger is a leading international company in the fields of medical and safety technology. Since 1889, Dräger has been developing advanced technical devices and solutions trusted by users all over the world. No matter where Dräger products are used: it’s always about life. Whether for use in clinical, industrial or mining applications, in firefighting or rescue services, Dräger products protect, support and save lives.
 

Management board & Supervisory board

CEO
Stefan Dräger
Management board
Gert-Hartwig Lescow, Anton Schrofner, Dr. Reiner Piske, Rainer Klug
Supervisory board
Stefan Lauer, Siegfrid Kasang, Astrid Hamker, Bettina van Almsick, Daniel Friedrich, Dr. Reinhard Zinkann, Maria Dietz, Nike Benten, Prof. Dr. Thorsten Grenz, Stephan Kruse, Thomas Rickers, Uwe Lüders
 

Company data

Name: Drägerwerk AG & Co. KGaA
Address: Moislinger Allee 53-55,D-23558 Lübeck
Phone: +49-451-882-0
Fax: +49-451-882-2080
E-mail: info@draeger.com
Internet: www.draeger.com
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 9.37%
IPO date: 6/21/2010

Investor relations

Name: Thomas Fischler
IR phone: +49-451-882-2685
IR Fax: +49-451-882-3296
IR e-mail: thomas.fischler@draeger.com

Company calendar

CW 31 | 7/28/2022 Interim Report 2nd Quarter/6 Months
CW 44 | 10/27/2022 Interim Report 3rd Quarter/9 Months
 

Main Shareholders

Familie Dräger
 
71.50%
Freefloat
 
17.31%
Norges Bank
 
2.99%
Oddo Asset Management
 
2.97%
Brandes Investment Partners, L.P.
 
2.93%
Lazard Small Caps Euro
 
2.30%